| Name | Johannes Siewert |
| Affiliation | Intitute of System Immunology
Chair of System Immunology I |
| Street | Versbacher Str. 9 |
| Zip Code | 97078 |
| City | Würzburg |
| Email | E-mail |
| Telephone | +49 931 31- 83311 |
| Homepage | Homepage |
| Section | Infection & Immunity |
| Title of Thesis Project | Elucidating the functional significance of unconventional T cells |
| Primary Supervisor | Prof. Dr. Wolfgang Kastenmüller |
| Member of Thesis Committee | PD Dr. Knut Ohlsen |
| Prof. Dr. Alma Zernecke-Madsen |
| |
| Conference Contribution | |
|
Publication |
|
Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer. Weiten R, Niemann M, Below E, Friker LL, Ralser DJ, Toma M, Kristiansen G, Hahn O, Zechel S, Grünwald V, Bald T, Siewert J, Pietsch T, Ritter M, Hölzel M, Eckstein M, Alajati A, Krausewitz P, Klümper N. Cancer Med. 2024 Jun;13(12):e7320. doi: 10.1002/cam4.7320.
|
|
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion. Kosnopfel C, Wendlinger S, Niessner H, Siewert J, Sinnberg T, Hofmann A, Wohlfarth J, Schrama D, Berthold M, Siedel C, Sauer B, Jayanthan A, Lenz G, Dunn SE, Schilling B, Schittek B. J Exp Clin Cancer Res. 2023 Jul 19;42(1):175. doi: 10.1186/s13046-023-02755-5.
|
|
| | Last update Publications 21.10.2024 |
|